Complementary use of gas chromatography–mass spectrometry, gas chromatography–atomic emission detection and nuclear magnetic resonance for identification of pharmaceutically related impurities of unknown structures
2004 ◽
Vol 1027
(1-2)
◽
pp. 93-102
◽
1996 ◽
Vol 686
(1)
◽
pp. 97-102
◽
1995 ◽
Vol 18
(6)
◽
pp. 367-372
◽
2019 ◽
Vol 14
(5)
◽
pp. 1934578X1985099
◽
2006 ◽
Vol 102
(5)
◽
pp. 413-424
◽
1991 ◽
Vol 173
(24)
◽
pp. 7790-7801
◽